Kenneth Alper, M.D is Associate Professor of Psychiatry and Neurology at New York University School of Medicine. He is author of over 70 peer-reviewed publications, books and book chapters, and his research and has been supported by the National Institute on Drug Abuse. His research on iboga alkaloids has spanned the disciplines of neuropharmacology, toxicology and medical ethnography. He edited and the only English language scientific text on ibogaine with Stanley Glick, the leading preclinical researcher on iboga alkaloids. Dr. Alper collaborated extensively with Howard Lotsof, the discover of ibogaine’s effect on drug dependence in humans. Their contributions including organizing the First International Conference on ibogaine in at NYU, and frequently cited papers on the first reported case series on the use of ibogaine for the indication of heroin detoxification and a study published in the Journal of Ethnopharmacology that combined qualitative and quantitative methods to provide a comprehensive overview on the global use of ibogaine. His clinical research has also included the relationship of trauma and abuse to dissociative symptomatology. His published collaborations with the New York City Office of Chief Medical Examiner and the NYU Department of Cardiology have valuably informed efforts to identify potential hazards associated with ibogaine use.
